FDA — authorised 30 October 1992
- Application: NDA019865
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: BETAPACE
- Indication: TABLET — ORAL
- Status: approved
FDA authorised sotolol on 30 October 1992
Yes. FDA authorised it on 30 October 1992.
LEGACY PHARMA holds the US marketing authorisation.